...
首页> 外文期刊>Oncology letters >A novel subtype of primary prostatic adenocarcinoma: A case report
【24h】

A novel subtype of primary prostatic adenocarcinoma: A case report

机译:新型原发性前列腺癌亚型:一例报告

获取原文
获取原文并翻译 | 示例

摘要

The present study reports the novel case of an 81-year-old male with prostatic adenocarcinoma (PAC), whose histopathological study revealed a pure urothelial carcinoma (UC) that originated, however, from the prostatic glandular epithelium. The levels of serum prostate-specific antigen (PSA) were extraordinarily high in this patient. An MRI scan indicated a prostatic neoplasm and no malignant changes were observed in the bladder or other areas of the urinary tract. Hematoxylin and eosin-stained sections revealed a diagnosis of pure UC with no other form of differentiation (typical adenocarcinoma or squamous differentiation). The immunohistochemical findings were positive for PSA and P504S, and negative for CK7, CK20, 34βE12 and p63. A diagnosis of primary PAC (solid carcinoma) originating from the prostate was made based on the clinical, histopathological and immunohistochemical observations. This case was susceptible to diagnostic errors, however, a novel subtype of primary PAC was identified and termed the UC-like subtype.
机译:本研究报告了一名81岁男性前列腺腺癌(PAC)的新病例,其组织病理学研究显示,纯泌尿道上皮癌(UC)起源于前列腺腺上皮。该患者的血清前列腺特异性抗原(PSA)水平异常高。 MRI扫描显示前列腺肿瘤,在膀胱或泌尿道其他区域未观察到恶性变化。苏木精和曙红染色切片显示诊断为纯UC,无其他形式的分化(典型的腺癌或鳞状分化)。免疫组化结果对PSA和P504S呈阳性,而对CK7,CK20、34βE12和p63呈阴性。根据临床,组织病理学和免疫组化的观察结果,诊断出前列腺癌为原发性PAC(实体癌)。该病例易受诊断错误的影响,但是,发现了一种新的原发性PAC亚型,称为UC样亚型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号